What is the main business of Igis Pro?

The main business activity of Igis Pro focuses on retail sale of medical and orthopaedic goods in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 3, 2025.

Where is the headquarters located?

The headquarters is located at: ul. Głębocka 54, 03-287 Warszawa.

Who is on the management board?

The management board consists of: Paweł Sołoducha (President of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from March 3, 2025 to December 31, 2025.

What revenue was generated?

In 2025, the company's revenue reached USD 169,010.

No, in 2025 the company was not profitable, reporting a net loss of USD 122,892.

What is the largest operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to USD 112,763 in 2025, representing 39% of all operating expenses.

Igis Prosp. z o.o.

Retail sale of medical and orthopaedic goods in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2025-03-03

Share capital

5 000,00 PLN

Registered address

ul. Głębocka 54/17, 03-287 Warszawa, Poland

Financials

Filing timeliness

1 of 1 financial statements was filed late (for 2025, 77 days late).

202530/09/2026

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 169.01kMedianUSD 344.45kAverageUSD 2.51m

Net profit

This companyUSD -122.89kMedianUSD 14.78kAverageUSD 165.71k

Operating costs

This companyUSD 291.50kMedianUSD 298.04kAverageUSD 2.27m

Assets

This companyUSD 69.63kMedianUSD 201.82kAverageUSD 1.23m

Industry

Authorized Representatives

Paweł Sołoducha – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Paweł Sołoduchaage 36	50	$1,350.62	100%

The articles of association require board approval for share transfers.

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2025-03-13.

mBank
79 1140 2004 0000 3502 8563 4596

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
MiroP.S.A.	$31,980,520.38	miro-med.pl
Nord Medicalsp. z o.o.	$5,476,355.54	nordmedical.pl
Apco Przedsiębiorstwo Wielobranżowesp. z o.o.	$1,788,421.73	apco.com.pl
Medinedsp. z o.o.	$1,783,239.84	medined.pl
Medico Systemssp. z o.o.	$1,647,640.58	medicosystems.pl
Gaminesp. z o.o.	$1,545,346.27	gamine.nyc
Lumamedsp. z o.o.	$1,045,746.03	lumamed.pl
Medical Smart Integratorsp. z o.o.	$317,541.89	medicalsmartintegrator.pl
Oneopticsp. z o.o.	$99,341.70	oneoptic.pl
Estetic Fillerssp. z o.o.	$63,161.08	esteticfillers.com